..."aminopyrine derivative"; and (c) The statement "Warning:— This drug may cause fatal agranulocytosis." (ii) Labeling on or within the package from which the drug is to be dispensed and any other labeling for the drug that furnishes or purports to furnish information for use, or which prescribes, recommends,...

...permitted labeling; and (2) The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed; Provided, however, That the informa-tion required by paragraphs (d) (1) and (2) of this section is...

...permitted labeling; and (2) The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed; Provided, however, That the information required by paragraphs (d) (1) and (2) of this section is not...

...permitted labeling; and (2) The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed. (3) The information required, and in the format specified, by §§ 201.56 and 201.57. (e) All labeling...

...Commissioner of Food and Drugs has concluded that the labeling on or within the package from which the product is to be dispensed, and any other labeling furnishing or purporting to furnish information for the use of these preparations, should bear conspicuously; (1) If subject to the labeling requirements...

...permitted labeling; and (ii) The same Information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug la to be dispensed; Provided, however. That the information required by subdivisions (i) and (il) of...

...permitted labeling; and (ii) The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug la to be dispensed; Provided, however, That the information required by subdivisions (i) and (il) of...

...relevant hazards, contraindications, side effects, and precautions, which is contained In the libeling on or within the package from which the drug Is to be ditpensed. It Is understood that all representations to this application regarding the components,...

...labeling was placed into use and the same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed. f. By revising paragraph (c) (3), (4), and (5) to be similar in effect to' paragraph (b) (3), (4),...

...compendium should in no way abrogate such label information. Additionally, the regulations require : "Labeling on or within the package from which the drug is to be dispensed bears adequate Information for its use, including indications, effects, dosages, routes, methods, and...